The company had placed its worldwide vaccine trials on hold for several days, but now says a safety review by regulators and reviewers is complete. No word yet when studies in the U.S. might resume.
(Image credit: Alastair Grant/AP)
The company had placed its worldwide vaccine trials on hold for several days, but now says a safety review by regulators and reviewers is complete. No word yet when studies in the U.S. might resume.